ASCO GU 2023 Conference Coverage
Avatar

FDA Announcement Based on the MAGNITUDE Trial: Niraparib With Abiraterone Acetate and Prednisone in Patients With mCRPC and Homologous Recombination Repair Gene Alterations

By ASCO GU 2023 Conference Coverage FEATURING Eleni Efstathiou
By ASCO GU 2023 Conference Coverage FEATURING Eleni Efstathiou
197 views
February 28, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

19:38
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Related Videos

21:43

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

444 views
16:05

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

1.5K views
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views
08:54

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

320 views
14:16

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

Insights from 2024 ASCO® GU Annual Meeting

E. Efstathiou

2.6K views
10:11

New

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Penn Medicine Abramson Cancer Center

D. Lee

267 views
08:54

New

Advances in Prostate Cancer Surgery

Penn Medicine Abramson Cancer Center

B. Schurhamer, T. Guzzo

211 views
07:05

New

Avoiding Unnecessary Operations in Prostate Cancer

Penn Medicine Abramson Cancer Center

P. Pierorazio

186 views
21:54

ASCO® 2024 Prostate Cancer Take-Home Messages

2024 ASCO® Annual Meeting Insights Hub

E. Efstathiou

592 views
18:43

Precision Therapies for Prostate Cancer

University of Miami Sylvester Comprehensive Cancer Center

M. Bilusic

381 views
12:10

GnRH Agonists vs. Antagonists in Prostate Cancer

Patrick Campbell

331 views
15:45

Evolving Strategies in First and Second-Line Treatment for mCRPC

International Urology Cancer Summit - IUCS

N. Agarwal

204 views
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views
34:26

ASCO® 2024 Summary: "Prostate Cancer Highlights"

2024 ASCO® Annual Meeting Insights Hub

N. Reizine, K. Tawagi

564 views
03:05

Testosterone Suppression and Recovery in Patients With Advanced Pros…

Benjamin L. Maughan

676 views
09:37

Total Therapy Considerations in Low-Volume mHSPC: Intensification vs…

Advanced Prostate Cancer Consensus Conference (APCCC)

O. Sartor

133 views
29:04

New

Review of mCRPC Updates From ESMO 2024

The View on GU | with Lalani & Wallis

A. A. Lalani, C. Wallis

76 views
05:27

Understanding PSMA PET Scans in Prostate Cancer Diagnosis

GRACE

K. Jatwani, K. Tawagi, M. Kurian

263 views
06:27

ASCO® 2024 Insights: "Evaluation of Persistence and Adherence for Or…

2024 ASCO® Annual Meeting Insights Hub

J. Hafron

638 views
27:04

Cancer Screening Molecular Tools

Fengting Yan

2.5K views
AUTOPLAY